This study is currently not recruiting participants.

A Phase 1 Study of a Prostate-Specific Membrane Antigen Targeting-Tubulysin Conjugate EC1169 in Patients with Recurrent Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study on the Safety and Dosage of an Investigational Medication

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to determine the safety of EC1169 and the best dose to use in humans in future studies. This study will also determine how EC1169 is distributed, broken down, passed and absorbed through your body and how quickly it is eliminated (leaves the body).

Detailed description of study

The purpose of this study is to determine the safety of EC1169 and the best dose to use in humans in future studies. This study will also determine how EC1169 is distributed, broken down, passed and absorbed through the body and how quickly it is eliminated.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: prostate cancer
  • Age: 18 years - 100 years
  • Gender: All

The purpose of this study is to determine the safety of an investigational medication and the best dose to use in humans in future studies. This study will also determine how the investigational medication is distributed, broken down, passed and absorbed through your body and how quickly it is eliminated (leaves the body).

Participants will undergo procedures to monitor how the investigational medication is processed by the body. This includes tracking how it is absorbed, broken down, and eliminated.

  • Who can participate: Participants must be adults aged 18-65, with no significant health issues and not currently taking other medications.
  • Study details: Participants will receive the investigational medication to assess its safety and optimal dosage. The study will track how the medication is processed in the body.
Updated on 19 Feb 2024. Study ID: 1702369348 (EC1169-01)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team